Immutep Limited Stock OTC Markets
Stocks
PRRUF
AU000000IMM6
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0500 USD | -.--% |
|
-.--% | -84.42% |
| 07-14 | Immutep Granted New US Patent for Cancer Treatment Methods | MT |
| 07-14 | Immutep Receives New US Patent for Cancer Treatment Method; Shares Down 4% | MT |
| Market Cap | 73.69M 51.45M 44.96M 41.49M 38.25M 72.09M 4.96B 496M 195M 2.43B 193M 189M 8.35B | P/E 2026 * |
-1.29x | P/E 2027 * | -1.84x |
|---|---|---|---|---|---|
| Enterprise Value | 8.69M 6.07M 5.3M 4.89M 4.51M 8.5M 584M 58.48M 23M 286M 22.78M 22.28M 985M | EV / Sales 2026 * |
0.5x | EV / Sales 2027 * | -1.11x |
| Free-Float |
96.98% | Yield 2026 * |
-
| Yield 2027 * | - |
| 3 months | -23.08% | ||
| 6 months | -80.28% | ||
| Current year | -84.42% |
| Current year | 0.04 |  | 0.25 |
| 1 year | 0.04 | | 0.33 |
| 3 years | 0.04 | | 0.33 |
| 5 years | 0.04 | | 0.51 |
| 10 years | 0.01 | | 0.8 |
| Manager | Title | Age | Since |
|---|---|---|---|
Marc Voigt
CEO | Chief Executive Officer | 53 | 09/07/2014 |
David Fang
DFI | Director of Finance/CFO | - | 01/03/2018 |
Stephan Winckels
CTO | Chief Tech/Sci/R&D Officer | - | 01/07/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Russell Howard
CHM | Chairman | 76 | 17/11/2017 |
Marc Voigt
BRD | Director/Board Member | 53 | 09/07/2014 |
Frédéric Triebel
BRD | Director/Board Member | 71 | 13/09/2022 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 51.45M | |
| +3.90% | -0.39% | +376.72% | +599.59% | 39.58B | |
| -1.70% | +4.46% | +7.46% | +57.67% | 34.69B | |
| -2.01% | -0.76% | +26.35% | -6.83% | 34.42B | |
| +0.06% | +0.34% | +2.32% | +29.30% | 27.11B | |
| +0.46% | -3.49% | - | - | 16.21B | |
| -0.04% | -0.09% | +68.48% | +117.39% | 15.36B | |
| +1.12% | +1.91% | +15.90% | +19.65% | 14.05B | |
| 0.00% | +1.36% | +15.74% | -30.62% | 13.02B | |
| -0.08% | -3.01% | +1,271.69% | +649.69% | 11.76B | |
| Average | +0.17% | +0.04% | +223.08% | +179.48% | 22.91B | |
| Weighted average by Cap. | +0.24% | +0.36% | +171.43% | +187.42% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 17.23M 12.03M 10.52M 9.7M 8.94M 16.86M 1.16B 116M 45.62M 568M 45.19M 44.2M 1.95B | 3.16M 2.2M 1.93M 1.78M 1.64M 3.09M 212M 21.25M 8.36M 104M 8.28M 8.1M 358M |
| Net income | -58.54M -40.88M -35.72M -32.96M -30.38M -57.27M -3.94B -394M -155M -1.93B -154M -150M -6.64B | -47.05M -32.85M -28.71M -26.49M -24.42M -46.03M -3.16B -317M -125M -1.55B -123M -121M -5.33B |
| Net Debt | -65M -45.39M -39.66M -36.6M -33.74M -63.59M -4.37B -437M -172M -2.14B -170M -167M -7.37B | -77.18M -53.89M -47.1M -43.46M -40.06M -75.5M -5.19B -519M -204M -2.54B -202M -198M -8.75B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- IMM Stock
- PRRUF Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
